In a major stride towards advancing gastrointestinal visualization technologies, AnX Robotica proudly announces the FDA clearance of its revolutionary NaviCam ProScan™. 

The clearance, granted through the rigorous De Novo Submission Process, marks a historic moment as ProScan becomes the first AI Assisted Reading Tool specifically designed to aid small bowel capsule endoscopy reviewers for adult patients suspected of small bowel bleeding.

The ProScan software, an artificial intelligence (AI) assisted reading tool, utilizes cutting-edge technology to reshape the landscape of gastroenterology. Positioned as a significant leap forward in capsule endoscopy, AnX Robotica's ProScan empowers physicians with the latest technology to efficiently care for their patients.

Renowned in the field of gastroenterology, Dr. Cristiano Spada, Professor of Gastroenterology and Director of Endoscopy and Digestive Surgery at Gemelli Hospital, expresses his excitement about the FDA clearance and said, "This groundbreaking AI Assisted Reading Tool represents a pivotal advancement in small bowel capsule endoscopy, particularly for patients suspected of gastrointestinal bleeding. This clearance marks a significant leap forward in our pursuit of elevating patient care standards and signifies a new era in gastroenterological diagnostics."

AnX Robotica emphasizes that ProScan is a valuable tool designed to complement clinician expertise rather than replace it. It acts as a support system, empowering healthcare professionals to make well-informed and efficient decisions with the aid of AI-assisted readings.

With ProScan's clearance and the innovative NaviCam® Magnetically Controlled Capsule Endoscopy System, AnX Robotica is committed to expanding the NaviCam® platform for additional visualization aids and therapeutic applications. 

The company's portfolio also includes the NaviCam® Colon System in Europe and the IntraMarX® 3D, radiopaque markers for colonic transit studies in the US.